Cargando…

The α(2) Adrenoceptor Agonist and Sedative/Anaesthetic Dexmedetomidine Excites Diverse Neuronal Types in the Ventrolateral Preoptic Area of Male Mice

The unique sedative activities with rapid arousal of dexmedetomidine (Dex) are not fully understood. Growing evidence suggests the involvement of the ventrolateral preoptic area (VLPO) in sleep–wake cycle. The major type in the VLPO is sleep-active neurons, inhibited by noradrenaline (NA(−) neurons)...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Sumei, Cheng, Xinqi, Zhang, Pingping, Wang, Yuanyin, Wang, Liecheng, Cheng, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388635/
https://www.ncbi.nlm.nih.gov/pubmed/37499170
http://dx.doi.org/10.1177/17590914231191016
_version_ 1785082164239400960
author Fan, Sumei
Cheng, Xinqi
Zhang, Pingping
Wang, Yuanyin
Wang, Liecheng
Cheng, Juan
author_facet Fan, Sumei
Cheng, Xinqi
Zhang, Pingping
Wang, Yuanyin
Wang, Liecheng
Cheng, Juan
author_sort Fan, Sumei
collection PubMed
description The unique sedative activities with rapid arousal of dexmedetomidine (Dex) are not fully understood. Growing evidence suggests the involvement of the ventrolateral preoptic area (VLPO) in sleep–wake cycle. The major type in the VLPO is sleep-active neurons, inhibited by noradrenaline (NA(−) neurons). The other type of neurons is activated by NA (NA(+) neurons), which are wake-active. Previous research showed that Dex-induced sedation and sleep homeostasis likely share common mechanisms. To explore the underlying mechanisms of Dex in the VLPO, in vivo polysomnography recording and in vitro electrophysiological recording were used in our study. Bath application of Dex (2 μM) increased the firing rate of both VLPO NA(−) and NA(+) neurons. Compared to the control group, there was no difference in the firing rate of both VLPO NA(−) and NA(+) neurons after Dex (2 μM) and RS79948 (1 mM) administration, an α(2) receptor antagonist. No difference was detected regarding resting membrane potential (RMP) amplitude of both VLPO NA (−) and NA(+) neurons after application of Dex (2 μM). Moreover, Dex (2 μM) significantly reduced the frequency of miniature inhibitory postsynaptic currents (mIPSCs) in both VLPO NA(−) and NA(+) neurons. These electrophysiology results were consistent with behavioral sedation, with increased nonrapid eye movement sleep (NREM sleep) and increased expression of c-Fos in the VLPO during the dark phase after intraperitoneal injection with Dex (80 μg/kg). In conclusion, Dex activates NA(−) and NA(+) neurons in the VLPO via presynaptic α(2) receptors. This mechanism may explain the unique sedative properties with rapid arousal. SUMMARY STATEMENT: Dexmedetomidine is an important ICU sedative. The mechanism of dexmedetomidine is not fully understood. Activating NA(−) and NA(+) neurons in the VLPO by dexmedetomidine using polysomnography and electrophysiological recording, this may explain the unique sedative properties with rapid arousal.
format Online
Article
Text
id pubmed-10388635
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-103886352023-08-01 The α(2) Adrenoceptor Agonist and Sedative/Anaesthetic Dexmedetomidine Excites Diverse Neuronal Types in the Ventrolateral Preoptic Area of Male Mice Fan, Sumei Cheng, Xinqi Zhang, Pingping Wang, Yuanyin Wang, Liecheng Cheng, Juan ASN Neuro Original Papers The unique sedative activities with rapid arousal of dexmedetomidine (Dex) are not fully understood. Growing evidence suggests the involvement of the ventrolateral preoptic area (VLPO) in sleep–wake cycle. The major type in the VLPO is sleep-active neurons, inhibited by noradrenaline (NA(−) neurons). The other type of neurons is activated by NA (NA(+) neurons), which are wake-active. Previous research showed that Dex-induced sedation and sleep homeostasis likely share common mechanisms. To explore the underlying mechanisms of Dex in the VLPO, in vivo polysomnography recording and in vitro electrophysiological recording were used in our study. Bath application of Dex (2 μM) increased the firing rate of both VLPO NA(−) and NA(+) neurons. Compared to the control group, there was no difference in the firing rate of both VLPO NA(−) and NA(+) neurons after Dex (2 μM) and RS79948 (1 mM) administration, an α(2) receptor antagonist. No difference was detected regarding resting membrane potential (RMP) amplitude of both VLPO NA (−) and NA(+) neurons after application of Dex (2 μM). Moreover, Dex (2 μM) significantly reduced the frequency of miniature inhibitory postsynaptic currents (mIPSCs) in both VLPO NA(−) and NA(+) neurons. These electrophysiology results were consistent with behavioral sedation, with increased nonrapid eye movement sleep (NREM sleep) and increased expression of c-Fos in the VLPO during the dark phase after intraperitoneal injection with Dex (80 μg/kg). In conclusion, Dex activates NA(−) and NA(+) neurons in the VLPO via presynaptic α(2) receptors. This mechanism may explain the unique sedative properties with rapid arousal. SUMMARY STATEMENT: Dexmedetomidine is an important ICU sedative. The mechanism of dexmedetomidine is not fully understood. Activating NA(−) and NA(+) neurons in the VLPO by dexmedetomidine using polysomnography and electrophysiological recording, this may explain the unique sedative properties with rapid arousal. SAGE Publications 2023-07-27 /pmc/articles/PMC10388635/ /pubmed/37499170 http://dx.doi.org/10.1177/17590914231191016 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Papers
Fan, Sumei
Cheng, Xinqi
Zhang, Pingping
Wang, Yuanyin
Wang, Liecheng
Cheng, Juan
The α(2) Adrenoceptor Agonist and Sedative/Anaesthetic Dexmedetomidine Excites Diverse Neuronal Types in the Ventrolateral Preoptic Area of Male Mice
title The α(2) Adrenoceptor Agonist and Sedative/Anaesthetic Dexmedetomidine Excites Diverse Neuronal Types in the Ventrolateral Preoptic Area of Male Mice
title_full The α(2) Adrenoceptor Agonist and Sedative/Anaesthetic Dexmedetomidine Excites Diverse Neuronal Types in the Ventrolateral Preoptic Area of Male Mice
title_fullStr The α(2) Adrenoceptor Agonist and Sedative/Anaesthetic Dexmedetomidine Excites Diverse Neuronal Types in the Ventrolateral Preoptic Area of Male Mice
title_full_unstemmed The α(2) Adrenoceptor Agonist and Sedative/Anaesthetic Dexmedetomidine Excites Diverse Neuronal Types in the Ventrolateral Preoptic Area of Male Mice
title_short The α(2) Adrenoceptor Agonist and Sedative/Anaesthetic Dexmedetomidine Excites Diverse Neuronal Types in the Ventrolateral Preoptic Area of Male Mice
title_sort α(2) adrenoceptor agonist and sedative/anaesthetic dexmedetomidine excites diverse neuronal types in the ventrolateral preoptic area of male mice
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388635/
https://www.ncbi.nlm.nih.gov/pubmed/37499170
http://dx.doi.org/10.1177/17590914231191016
work_keys_str_mv AT fansumei thea2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT chengxinqi thea2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT zhangpingping thea2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT wangyuanyin thea2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT wangliecheng thea2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT chengjuan thea2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT fansumei a2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT chengxinqi a2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT zhangpingping a2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT wangyuanyin a2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT wangliecheng a2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice
AT chengjuan a2adrenoceptoragonistandsedativeanaestheticdexmedetomidineexcitesdiverseneuronaltypesintheventrolateralpreopticareaofmalemice